{"hands_on_practices": [{"introduction": "Understanding the flow of energy in a cell is central to biochemistry. This practice delves into the quantitative heart of carbohydrate metabolism by comparing the energy yield, in the form of Adenosine Triphosphate ($ATP$), from the complete aerobic oxidation of glucose versus anaerobic fermentation. By meticulously accounting for the ATP produced in glycolysis, the tricarboxylic acid (TCA) cycle, and oxidative phosphorylation, you will gain a concrete appreciation for the profound energetic advantage of aerobic respiration and the biochemical consequences of its impairment [@problem_id:5209816].", "problem": "A clinical laboratory is asked to interpret the energetic impact of pyruvate dehydrogenase (PDH) inhibition on glucose metabolism in a human skeletal muscle cell line. Baseline studies indicate predominant cytosolic nicotinamide adenine dinucleotide (NADH) transfer to the electron transport chain via the glycerol phosphate shuttle rather than the malate–aspartate shuttle. Under PDH inhibition, oxygen consumption drops to negligible levels and lactate release rises, consistent with fermentation to lactate. Use the following well-tested facts as the fundamental base for your derivation:\n\n- In glycolysis, one mole of glucose is converted to two moles of pyruvate, producing a net of $2$ molecules of adenosine triphosphate (ATP) and $2$ molecules of NADH in the cytosol.\n- Under anaerobic conditions, pyruvate is reduced to lactate to reoxidize cytosolic NADH, and no additional ATP is made beyond the substrate-level phosphorylation in glycolysis.\n- Under aerobic conditions with fully functional mitochondria, pyruvate is oxidized to acetyl-coenzyme A by pyruvate dehydrogenase (PDH), yielding $1$ NADH per pyruvate. Each acetyl-coenzyme A enters the tricarboxylic acid (TCA) cycle, yielding per acetyl-coenzyme A: $3$ NADH, $1$ flavin adenine dinucleotide (FADH$_2$), and $1$ guanosine triphosphate (GTP), which is energetically equivalent to $1$ ATP.\n- In the glycerol phosphate shuttle, each cytosolic NADH is converted to mitochondrial FADH$_2$; in oxidative phosphorylation, the commonly accepted adenosine triphosphate per oxygen atom (P/O) ratios are $2.5$ ATP per mitochondrial NADH and $1.5$ ATP per mitochondrial FADH$_2$.\n\nStarting only from these facts, derive the net ATP yield per mole of glucose under aerobic conditions with the glycerol phosphate shuttle, and under anaerobic conditions with PDH inhibited and metabolism proceeding to lactate. Then compute the signed change in ATP yield per mole of glucose defined as\n$$\\Delta Y = Y_{\\text{anaerobic}} - Y_{\\text{aerobic}}.$$\nExpress your final answer as a single real number representing the change in $\\mathrm{mol}$ ATP per $\\mathrm{mol}$ glucose. No rounding is required.", "solution": "The problem statement is scientifically grounded, self-contained, and well-posed. It provides a set of standard, accepted facts about central carbohydrate metabolism and asks for a quantitative derivation based on these facts. The problem is valid and can be solved as stated.\n\nThe task is to compute the change in ATP yield per mole of glucose, $\\Delta Y$, when metabolism shifts from aerobic respiration to anaerobic fermentation. This is defined as $\\Delta Y = Y_{\\text{anaerobic}} - Y_{\\text{aerobic}}$. We must first calculate the net ATP yield for each condition, $Y_{\\text{anaerobic}}$ and $Y_{\\text{aerobic}}$, based only on the provided facts.\n\n**1. Calculation of Net ATP Yield under Anaerobic Conditions ($Y_{\\text{anaerobic}}$)**\n\nUnder anaerobic conditions, cellular metabolism shifts to fermentation. The problem states that pyruvate is reduced to lactate to regenerate cytosolic NAD$^+$ from the NADH produced during glycolysis.\n\n- According to Fact 1, the process of glycolysis converts $1$ mole of glucose into $2$ moles of pyruvate, with a net production of $2$ moles of ATP via substrate-level phosphorylation.\n- Fact 2 states that in the subsequent reduction of pyruvate to lactate, no additional ATP is synthesized. The purpose of this step is to reoxidize the $2$ moles of cytosolic NADH produced during glycolysis, allowing glycolysis to continue.\n\nTherefore, the total net yield of ATP per mole of glucose under anaerobic conditions is solely the ATP produced during glycolysis.\n$$Y_{\\text{anaerobic}} = 2 \\, \\text{ATP}$$\n\n**2. Calculation of Net ATP Yield under Aerobic Conditions ($Y_{\\text{aerobic}}$)**\n\nUnder aerobic conditions, glucose is completely oxidized to CO$_2$ and H$_2$O. We will systematically account for the ATP produced at each stage of the process, starting with $1$ mole of glucose.\n\n- **Glycolysis**: As per Fact 1, glycolysis of $1$ mole of glucose yields:\n  - Net $2$ ATP from substrate-level phosphorylation.\n  - $2$ NADH in the cytosol.\n\n- **Shuttle System**: The problem specifies the use of the glycerol phosphate shuttle. According to Fact 4, each mole of cytosolic NADH is used to generate one mole of FADH$_2$ inside the mitochondrion.\n  - $2$ cytosolic NADH $\\rightarrow 2$ mitochondrial FADH$_2$.\n\n- **Pyruvate Oxidation**: Glycolysis produces $2$ moles of pyruvate. According to Fact 3, each mole of pyruvate is oxidized by the pyruvate dehydrogenase (PDH) complex to $1$ mole of acetyl-coenzyme A (acetyl-CoA), yielding $1$ mole of NADH within the mitochondrial matrix.\n  - $2$ pyruvate $\\rightarrow 2$ acetyl-CoA $+ 2$ mitochondrial NADH.\n\n- **Tricarboxylic Acid (TCA) Cycle**: The $2$ moles of acetyl-CoA enter the TCA cycle. According to Fact 3, for each mole of acetyl-CoA, the cycle produces $3$ NADH, $1$ FADH$_2$, and $1$ GTP. The GTP is energetically equivalent to $1$ ATP.\n  - For $2$ moles of acetyl-CoA, the yield is:\n    - $2 \\times 3 = 6$ mitochondrial NADH.\n    - $2 \\times 1 = 2$ mitochondrial FADH$_2$.\n    - $2 \\times 1 = 2$ GTP, which is equivalent to $2$ ATP from substrate-level phosphorylation.\n\n- **Total ATP from Oxidative Phosphorylation**: We sum all mitochondrial reducing equivalents and use the P/O ratios from Fact 4 ($2.5$ ATP per NADH, $1.5$ ATP per FADH$_2$).\n  - Total mitochondrial NADH = $2$ (from PDH) $+ 6$ (from TCA cycle) = $8$ NADH.\n  - Total mitochondrial FADH$_2$ = $2$ (from glycerol phosphate shuttle) $+ 2$ (from TCA cycle) = $4$ FADH$_2$.\n  - ATP from NADH: $8 \\, \\text{NADH} \\times 2.5 \\, \\frac{\\text{ATP}}{\\text{NADH}} = 20 \\, \\text{ATP}$.\n  - ATP from FADH$_2$: $4 \\, \\text{FADH}_2 \\times 1.5 \\, \\frac{\\text{ATP}}{\\text{FADH}_2} = 6 \\, \\text{ATP}$.\n  - Total ATP from oxidative phosphorylation = $20 + 6 = 26 \\, \\text{ATP}$.\n\n- **Total Net ATP Yield ($Y_{\\text{aerobic}}$)**: We sum the ATP produced from both substrate-level phosphorylation and oxidative phosphorylation.\n  - ATP from substrate-level phosphorylation = $2$ (from glycolysis) $+ 2$ (from TCA cycle as GTP) = $4 \\, \\text{ATP}$.\n  - ATP from oxidative phosphorylation = $26 \\, \\text{ATP}$.\n  - Total yield: $Y_{\\text{aerobic}} = 4 + 26 = 30 \\, \\text{ATP}$.\n\n**3. Calculation of the Change in ATP Yield ($\\Delta Y$)**\n\nFinally, we compute the signed change in ATP yield as defined in the problem statement.\n$$\\Delta Y = Y_{\\text{anaerobic}} - Y_{\\text{aerobic}}$$\nSubstituting the calculated values:\n$$\\Delta Y = 2 - 30 = -28$$\nThe change in ATP yield per mole of glucose when shifting from aerobic to anaerobic metabolism is $-28$ moles of ATP.", "answer": "$$\\boxed{-28}$$", "id": "5209816"}, {"introduction": "In clinical diagnostics, the ratio of key metabolites can often be more informative than their absolute concentrations. This exercise explores how the lactate-to-pyruvate ratio serves as a powerful indicator of the cytosolic redox state ($\\frac{[\\text{NADH}]}{[\\text{NAD}^+]}$), allowing for the differential diagnosis of lactic acidosis. By analyzing hypothetical patient data, you will apply fundamental principles of the lactate dehydrogenase equilibrium to distinguish between metabolic blocks caused by hypoxia, mitochondrial dysfunction, or a specific enzyme deficiency like that of the pyruvate dehydrogenase (PDH) complex [@problem_id:5209896].", "problem": "A fasting adult patient’s venous plasma was collected into fluoride-oxalate tubes, immediately placed on ice, and deproteinized within $5$ minutes to minimize ongoing glycolysis. An enzymatic spectrophotometric assay yielded the following stabilized concentrations: plasma lactate $[\\text{lactate}] = 4.60 \\ \\text{mmol} \\ \\text{L}^{-1}$ and plasma pyruvate $[\\text{pyruvate}] = 0.570 \\ \\text{mmol} \\ \\text{L}^{-1}$. From a biochemical perspective grounded in basic carbohydrate metabolism and redox balance, use these measured values to compute the lactate-to-pyruvate ratio and infer the most likely predominant defect category among the following: hypoxic (systemic oxygen delivery/utilization limitation), mitochondrial respiratory chain impairment, or enzymatic defect at the pyruvate dehydrogenase (PDH) complex level.\n\nYour tasks:\n- Compute the lactate-to-pyruvate ratio $R$ using only the given concentrations.\n- Based on first-principles reasoning about the cytosolic redox state and pathway fluxes, assign a code $C$ to the predominant defect category using the following mapping: hypoxic $\\rightarrow 1$, mitochondrial respiratory chain defect $\\rightarrow 2$, pyruvate dehydrogenase complex defect $\\rightarrow 3$.\n\nRound $R$ to three significant figures. Report $R$ as a dimensionless quantity. For the categorical inference, provide only the code $C$ as an integer.", "solution": "The problem will be validated by first extracting the given information and then assessing its scientific validity and structural integrity.\n\n### Step 1: Extract Givens\n-   Sample source: Fasting adult patient, venous plasma.\n-   Sample preparation: Collected in fluoride-oxalate tubes, placed on ice, deproteinized within $5$ minutes.\n-   Measured concentration of plasma lactate: $[\\text{lactate}] = 4.60 \\ \\text{mmol} \\ \\text{L}^{-1}$.\n-   Measured concentration of plasma pyruvate: $[\\text{pyruvate}] = 0.570 \\ \\text{mmol} \\ \\text{L}^{-1}$.\n-   Task 1: Compute the lactate-to-pyruvate ratio, denoted as $R$, rounded to three significant figures.\n-   Task 2: Infer the predominant defect category and assign a code, $C$.\n-   Defect category mapping:\n    -   Hypoxic condition: $C=1$.\n    -   Mitochondrial respiratory chain defect: $C=2$.\n    -   Pyruvate dehydrogenase (PDH) complex defect: $C=3$.\n\n### Step 2: Validate Using Extracted Givens\n-   **Scientific Groundedness**: The problem is scientifically sound. It is based on the well-established biochemical relationship between lactate, pyruvate, and the cytosolic redox state, as governed by the lactate dehydrogenase (LDH) reaction. The lactate-to-pyruvate (L/P) ratio is a standard diagnostic tool for investigating the etiology of lactic acidosis. The provided concentrations, while elevated, are clinically plausible for a patient with a metabolic disorder. The described sample handling (fluoride inhibitor for glycolysis, rapid deproteinization) is appropriate to ensure the measured values reflect the *in vivo* state.\n-   **Well-Posedness**: The problem is well-posed. It provides all the necessary quantitative data to calculate the ratio $R$. The inference of the defect category $C$ is a standard application of biochemical principles to interpret laboratory data, leading to a unique and meaningful conclusion within the defined context.\n-   **Objectivity**: The problem is stated using objective, precise scientific language. The tasks are analytical and require reasoning based on established metabolic pathways, not subjective opinion.\n\n### Step 3: Verdict and Action\nThe problem is deemed **valid** as it is scientifically grounded, well-posed, and objective. A full solution will be provided.\n\n### Solution\nThe solution is a two-part process: first, the calculation of the lactate-to-pyruvate ratio ($R$), and second, the inference of the underlying metabolic defect ($C$) based on this ratio and fundamental biochemical principles.\n\n**Part 1: Calculation of the Lactate-to-Pyruvate Ratio ($R$)**\n\nThe lactate-to-pyruvate ratio, $R$, is defined as the concentration of lactate divided by the concentration of pyruvate. Using the provided values:\n$$\nR = \\frac{[\\text{lactate}]}{[\\text{pyruvate}]}\n$$\nSubstituting the given concentrations:\n$$\nR = \\frac{4.60 \\ \\text{mmol} \\ \\text{L}^{-1}}{0.570 \\ \\text{mmol} \\ \\text{L}^{-1}}\n$$\nThe units $\\text{mmol} \\ \\text{L}^{-1}$ cancel, yielding a dimensionless quantity.\n$$\nR \\approx 8.070175...\n$$\nRounding to three significant figures, as required by the problem statement:\n$$\nR = 8.07\n$$\n\n**Part 2: Inference of the Predominant Defect Category ($C$)**\n\nThe inference is based on the lactate dehydrogenase (LDH) equilibrium in the cytosol, which couples the interconversion of pyruvate and lactate to the cytosolic redox state, represented by the ratio of reduced nicotinamide adenine dinucleotide ($[\\text{NADH}]$) to its oxidized form ($[\\text{NAD}^+]$).\n\nThe LDH reaction is:\n$$\n\\text{Pyruvate} + \\text{NADH} + \\text{H}^+ \\rightleftharpoons \\text{Lactate} + \\text{NAD}^+\n$$\nThe equilibrium constant, $K_{eq}$, for this reaction is given by:\n$$\nK_{eq} = \\frac{[\\text{Lactate}][\\text{NAD}^+]}{[\\text{Pyruvate}][\\text{NADH}][\\text{H}^+]}\n$$\nRearranging this equation to express the lactate-to-pyruvate ratio gives:\n$$\n\\frac{[\\text{Lactate}]}{[\\text{Pyruvate}]} = K_{eq} \\cdot [\\text{H}^+] \\cdot \\frac{[\\text{NADH}]}{[\\text{NAD}^+]}\n$$\nUnder physiological conditions where intracellular pH (and thus $[\\text{H}^+]$) is tightly regulated, the lactate-to-pyruvate ratio ($R$) is directly proportional to the cytosolic $[\\text{NADH}]/[\\text{NAD}^+]$ ratio:\n$$\nR \\propto \\frac{[\\text{NADH}]}{[\\text{NAD}^+]}\n$$\nA normal, healthy fasting L/P ratio is typically in the range of $10$ to $15$. The calculated ratio $R = 8.07$ is within or slightly below this normal range. However, the absolute concentrations of both lactate ($4.60 \\ \\text{mmol} \\ \\text{L}^{-1}$) and pyruvate ($0.570 \\ \\text{mmol} \\ \\text{L}^{-1}$) are significantly elevated (normal fasting lactate $< 2 \\ \\text{mmol} \\ \\text{L}^{-1}$, normal pyruvate $< 0.15 \\ \\text{mmol} \\ \\text{L}^{-1}$), indicating a state of lactic acidosis. The key to the diagnosis lies in interpreting the L/P ratio in the context of these high absolute values.\n\nLet us analyze the three proposed defect categories:\n\n1.  **Hypoxic ($C=1$) or Mitochondrial Respiratory Chain Defect ($C=2$)**:\n    Both conditions impair oxidative phosphorylation, the primary mitochondrial pathway for re-oxidizing NADH to NAD$^+$. In hypoxia, oxygen, the final electron acceptor, is unavailable. In a respiratory chain defect, one of the protein complexes is non-functional. In either case, the mitochondrial $[\\text{NADH}]/[\\text{NAD}^+]$ ratio increases sharply. This high redox potential is transferred to the cytosol via shuttle systems (e.g., malate-aspartate shuttle), causing the cytosolic $[\\text{NADH}]/[\\text{NAD}^+]$ ratio to rise significantly. According to the LDH equilibrium, this high $[\\text{NADH}]/[\\text{NAD}^+]$ ratio strongly drives the conversion of pyruvate to lactate. This results in a high lactate concentration but a relatively low pyruvate concentration, leading to a markedly elevated lactate-to-pyruvate ratio, typically greater than $25$. The observed ratio of $R = 8.07$ is inconsistent with this profile.\n\n2.  **Pyruvate Dehydrogenase (PDH) Complex Defect ($C=3$)**:\n    The PDH complex catalyzes the oxidative decarboxylation of pyruvate to acetyl-CoA, which is the entry point into the Krebs cycle. A defect in this enzyme complex creates a metabolic block, preventing pyruvate from being consumed by the mitochondria. This leads to a primary accumulation of pyruvate in the cytosol. The excess pyruvate is then shunted into other pathways, principally its reduction to lactate by LDH. This causes the concentration of both pyruvate and lactate to rise. Crucially, this type of defect does not primarily impair the mitochondrial respiratory chain's ability to re-oxidize NADH. Therefore, the cytosolic $[\\text{NADH}]/[\\text{NAD}^+]$ ratio is not significantly elevated and remains relatively normal. Consequently, the lactate-to-pyruvate ratio ($R$) also remains in the normal range, even in the presence of severe lactic acidosis.\n\nThe patient's data—significantly elevated lactate and pyruvate with a normal-to-low lactate-to-pyruvate ratio ($R = 8.07$)—is a classic biochemical signature for a primary defect in pyruvate metabolism, specifically a deficiency in the pyruvate dehydrogenase (PDH) complex.\n\nTherefore, the predominant defect category corresponds to code $C=3$.", "answer": "$$\n\\boxed{\\begin{pmatrix} 8.07 & 3 \\end{pmatrix}}\n$$", "id": "5209896"}, {"introduction": "While blood glucose measurements provide a snapshot in time, long-term glycemic control is often a more critical indicator of metabolic health, especially in the management of diabetes. This practice demonstrates the clinical translation of a long-term biomarker, Hemoglobin A1c (HbA1c), into an Estimated Average Glucose (eAG), which is more intuitive for patients and clinicians. This exercise not only involves a straightforward calculation but also challenges you to consider the real-world factors, such as hemoglobin variants and red blood cell lifespan, that can complicate the interpretation of this vital diagnostic test [@problem_id:5209891].", "problem": "A clinical laboratory aligned to the National Glycohemoglobin Standardization Program (NGSP) reports a patient’s Hemoglobin A1c (HbA1c) on the percent scale as $8.2$. The laboratory wishes to translate this into Estimated Average Glucose (eAG) in milligrams per deciliter using the widely accepted linear calibration derived from continuous glucose monitoring and capillary profiles in large cohorts, which links mean glycemia to Hemoglobin A1c (HbA1c). For this calibration, use the relationship $eAG = 28.7 \\times \\text{HbA1c} - 46.7$, where HbA1c is entered as its percent value (for example, $7.0$ corresponds to seven percent) and eAG is returned in milligrams per deciliter. \n\nCompute the patient’s eAG. Round your final numeric result to four significant figures and express it in milligrams per deciliter. Then, in a short scientific justification, discuss how the presence of hemoglobin variants or hemolysis could affect the uncertainty of the eAG inferred from HbA1c, making sure to identify the direction of expected bias and the mechanistic basis for that bias in a laboratory diagnostics context. Your final reported answer must be a single number only, as specified, while your reasoning should address the uncertainty qualitatively.", "solution": "The aim is to compute Estimated Average Glucose (eAG) from Hemoglobin A1c (HbA1c) and to reason about uncertainty introduced by biological and analytical factors such as hemoglobin variants and hemolysis. The fundamental basis is that nonenzymatic glycation of the N-terminal valine of the hemoglobin beta chain proceeds at a rate approximately proportional to ambient glucose concentration over the lifespan of red blood cells (RBCs). Therefore, the long-term mean glucose level is reflected in Hemoglobin A1c (HbA1c). Large cohort studies integrating continuous glucose monitoring and frequent capillary measurements have established a well-tested linear relationship between mean glucose and Hemoglobin A1c (HbA1c) on the NGSP percent scale, summarized by the calibration\n$$\neAG \\;=\\; a \\times H \\;-\\; b,\n$$\nwhere $H$ is Hemoglobin A1c (HbA1c) in percent units, $a$ is a slope parameter linking changes in Hemoglobin A1c (HbA1c) to changes in eAG, and $b$ is an intercept accounting for baseline offset. For the NGSP-aligned calibration, $a = 28.7$ and $b = 46.7$, yielding the operative formula\n$$\neAG \\;=\\; 28.7 \\times H \\;-\\; 46.7.\n$$\n\nStep 1: Symbolic application of the relationship. Let $H$ denote the NGSP Hemoglobin A1c (HbA1c) value (in percent units). Then\n$$\neAG(H) \\;=\\; 28.7\\,H - 46.7.\n$$\n\nStep 2: Substitute the patient’s value. The reported Hemoglobin A1c (HbA1c) is $H = 8.2$. Therefore,\n$$\neAG \\;=\\; 28.7 \\times 8.2 - 46.7.\n$$\nCompute the product first:\n$$\n28.7 \\times 8.2 \\;=\\; 235.34.\n$$\nSubtract the intercept:\n$$\neAG \\;=\\; 235.34 - 46.7 \\;=\\; 188.64.\n$$\n\nStep 3: Rounding instruction. The problem requests that the answer be rounded to four significant figures. Thus,\n$$\neAG \\approx 188.6.\n$$\nThis value is to be reported in milligrams per deciliter.\n\nDiscussion of uncertainty due to hemoglobin variants and hemolysis. The mechanistic basis for uncertainty rests on two domains: analytical interference and altered RBC kinetics.\n\n1) Hemoglobin variants. Variants such as sickle hemoglobin (HbS), hemoglobin C (HbC), or others can induce method-dependent analytical biases in Hemoglobin A1c (HbA1c) measurement. For example, certain high-performance liquid chromatography (HPLC) methods may co-elute variant fractions with the Hemoglobin A1c (HbA1c) peak or alter peak shape, leading to overestimation or underestimation of Hemoglobin A1c (HbA1c) depending on the assay’s chromatographic separation and detection. Since the eAG mapping is linear with slope $28.7$, any Hemoglobin A1c (HbA1c) bias $\\Delta H$ propagates as\n$$\n\\Delta eAG \\;=\\; 28.7 \\times \\Delta H,\n$$\nso even a small method-dependent bias (for example, $\\Delta H = -0.5$ in percent units due to negative bias with a given variant) translates into a nontrivial shift in eAG (here, $\\Delta eAG = -14.35$ in milligrams per deciliter), falsely suggesting lower mean glycemia. Therefore, the presence of hemoglobin variants increases uncertainty and may systematically bias the eAG.\n\n2) Hemolysis and altered RBC lifespan. Hemolysis shortens RBC survival, reducing the time available for glycation. For a given true mean glucose, a shorter RBC lifespan lowers Hemoglobin A1c (HbA1c), which then underestimates the true eAG. Mechanistically, Hemoglobin A1c (HbA1c) integrates glucose exposure over RBC age; if fewer older RBCs are present because of increased turnover, the population-averaged glycation declines, biasing Hemoglobin A1c (HbA1c) downward. In the linear mapping, this again produces a negative $\\Delta H$ and thus a negative $\\Delta eAG = 28.7 \\times \\Delta H$, yielding an eAG that is too low relative to the true mean glycemia. Conversely, prolonged RBC lifespan would inflate Hemoglobin A1c (HbA1c) and eAG relative to true mean glucose.\n\nLaboratory diagnostics implications. Because both hemoglobin variants and hemolysis can bias Hemoglobin A1c (HbA1c), the uncertainty of eAG increases in these conditions. Best practice includes using an assay method validated as noninterfered for the suspected variant, verifying for hemolysis or hemoglobinopathies (for example, by reviewing HPLC flags or performing confirmatory testing), and considering alternative glycemic indices less sensitive to RBC kinetics, such as serum fructosamine or glycated albumin, and integration with continuous glucose monitoring when red blood cell dynamics are abnormal.\n\nThe computed numeric result remains the central estimate under the assumption that the calibration applies and that analytical interferences and RBC kinetics are typical; however, in the presence of hemoglobin variants or hemolysis, that central estimate may be biased as described.\n\nTherefore, the eAG rounded to four significant figures is $188.6$ milligrams per deciliter.", "answer": "$$\\boxed{188.6}$$", "id": "5209891"}]}